Blood neurofilament light as a potential endpoint in Phase 2 studies in MS

OBJECTIVES: To assess whether neurofilament light chain (NfL) could serve as an informative endpoint in Phase 2 studies in patients with relapsing–remitting multiple sclerosis (RRMS) and estimate the sample size requirements with NfL as the primary endpoint. METHODS: Using data from the Phase 3 FREE...

Descripción completa

Detalles Bibliográficos
Autores principales: Sormani, Maria Pia, Haering, Dieter A., Kropshofer, Harald, Leppert, David, Kundu, Uma, Barro, Christian, Kappos, Ludwig, Tomic, Davorka, Kuhle, Jens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562031/
https://www.ncbi.nlm.nih.gov/pubmed/31211172
http://dx.doi.org/10.1002/acn3.795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562031/
https://www.ncbi.nlm.nih.gov/pubmed/31211172
http://dx.doi.org/10.1002/acn3.795

Ejemplares similares